Program: IgY-112
Stage: Discovery
Celiac disease IgY are capsules containing polyclonal antibodies IgY that block the interaction of hypersensitive or excessive mucosal immune responses with microbial and protein components that are associated with celiac disease pathogenesis. The capsule formula is designed to deliver the antibodies directly to the small intestine where the inflammation takes place for better management of the disease.
Please contact us to learn more about Celiac disease IgY or to explore partnership opportunities.